Nuvalent shares surge 39% after UK’s GSK agrees to buy the cancer drugmaker for $10.6 billion
The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and drugmakers’ race to bolster pipelines.
He left Goldman Sachs after 26 years with no job lined up. Now he runs one of America’s oldest banks
After 26 years at Goldman Sachs, Robin Vince walked away without another job lined up. In this episode of “Executive Decisions,” the BNY CEO reflects on why he stepped off a successful career path, what he learned during the global financial crisis and…
China’s May shipments to U.S. clock 5-year high growth at 35% as overall exports jump on tech boost
Exports to the U.S. surged the most since March 2021, extending a rebound following a long streak of double-digit declines for the most of last year.
Germany and France drop joint fighter jet project
The leaders of Germanyand France have agreed to scrap a landmark project to develop and build a new-generation fighter jet, officials said Monday.
CNBC Daily Open: Tim Cook’s last WWDC, tech IPOs and Middle East tensions
Tensions in the Middle East still continue to simmer as Israeli Prime Minister Benjamin Netanyahu warned the war “has not yet ended”
Asia chip-linked shares recover after U.S. peers bounce back
In the U.S., chip stocks powered gains on Monday, helping the S&P 500 gain 0.3%, while the tech-heavy Nasdaq Composite advanced 0.86%.
Perplexity plans IPO in 2028 regardless of what happens to Anthropic or OpenAI, CEO tells CNBC
Perplexity CEO Aravind Srinivas’ comments come after AI giant Anthropic confidentially filed to go public.
CNBC’s The China Connection newsletter: Humanoid robots are great, but they need buyers too
Chinese companies ramp up humanoid robot development and production, often with global aims.
Stock futures rise as chip rebound lifts S&P 500 to winning day; South Korea stocks jump 7%: Live updates
A rally in chip stocks boosted the S&P 500 and Nasdaq Composite on Monday.
